1Andersong CS, Jamrozik KD, Burvill PW. Determining the incidence of different subtype of stroke: rseult from the Perth Commnity Stroke study. 1989- 1990. Med J Aust, 1993, 158(2): 85-89
2ArakawaS, SakuY, IbayashiS. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke, 1998, 29( ): 1806-1809
3Thrift AG, McNeil JJ. Andrew Forbes for the Melboume Risk Factor Study (MERFS) Group Risk factor for cerebral hemorrhage in the era of well-controlled hypertension. Stroke, 1996, 27(11): 2020-2025
4Thrift AG, McNeil JJ, Donnan GA. The risk of intracerebral haemorrhage with smoking. The Melboume Risk Factor Study Group. Cerebrovasc Dis, 1999, 9(1): 34-39
6O'Donnell HC, Rosand J, Knudsen KA. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med,2000, 342(4): 240 - 245
7Greenberg SM, Briggs ME, Hyman BT, et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke, 1996, 27(8): 1333- 1337
8Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy . Neurology,1998, 50(4) :961 - 965
9Greenberg SM, Megan E, Hyman BT. Apolipoprotein Eε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke, 1996, 27(8): 1333-1337
10Adam DJ, Bicth CJG. Kinetic mechanism of the inhibition of catepsin G by α1 - antichymotrypsin and α1 - proteinase inhibitor. Biochemistry,1998, 37(32): 11239- 11245
